This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various biologically active molecules. Its structure, featuring both amino and hydroxymethyl functional groups, makes it a valuable building block for the development of drugs targeting neurological disorders, particularly those involving modulation of neurotransmitter systems. It is often employed in the preparation of pyrrolidine-based compounds, which are known for their potential therapeutic effects in conditions such as Parkinson's disease, depression, and anxiety. Additionally, its chiral nature allows for the creation of enantiomerically pure substances, enhancing the specificity and efficacy of the resulting pharmaceutical agents.